The PKD Foundation’s principal mission is to support basic, translational, and clinical research that will benefit patients with autosomal dominant and autosomal recessive polycystic kidney disease (ADPKD and ARPKD).
Under this RFA, the PKD Foundation solicits research grant applications in the following areas:
- Basic research to enhance understanding of molecular basis of PKD and its pathobiology
- Translational research to accelerate development of predictive and therapeutic strategies for PKD
- Clinical research such as small pilot studies
- Epidemiology/data analysis research to conduct secondary data analyses utilizing existing database resources, or to develop new statistical methodologies or test hypotheses using existing data
The PKD Foundation encourages proposals in the following topic areas*:
- Autosomal Recessive PKD (ARPKD)
- ADPKD in children
- Innovative approaches to machine learning
- Lifestyle interventions (e.g., in dietary habits)
- Epidemiology/ data analysis (e.g., using existing datasets)
- Extra-renal manifestations of PKD, including but not limited to, congenital hepatic fibrosis, polycystic liver disease, and intracranial aneurysms
- Clinical care disparities (e.g., race, ethnicity, socioeconomic status, rural versus urban)
- Drug delivery mechanisms
*Note that these areas of interest will not be scored preferentially during review.
Thanks to international PKD Foundation partnerships, special consideration will be given to grant applications for research conducted in:
- Canada (made possible by a collaboration with the PKD Foundation of Canada)
- Australia (made possible by a collaboration with the PKD Australia)
Applicants must submit a pre-application to be considered for funding and will be notified in October as to whether they are invited to submit a full grant proposal. Full applications will not be accepted unless notification of invitation has been received from the PKD Foundation.
Application Calendar | |
---|---|
Pre-Application Submissions Begin | July 1, 2025 |
Pre-Application Deadline | August 11, 2025 @ 5 PM CST |
Review Period | August – October 2025 |
Invitations to submit full applications* | October 2025 |
Full Application Deadline | January 12, 2026 @ 5 PM CST |
Review Period | January – April 2026 |
Applicant Notification | May 2026 |
Funding Cycle | July 1, 2026 – June 30, 2028 |
Applicants must submit a pre-application in order to be considered for funding. You’ll be notified by October as to whether or not you’re invited to submit a full grant proposal. Full applications will not be accepted unless notification of invitation has been received from PKD Foundation.
Pre-application requirements:
- Letter of Intent
- Abstract (3,500 characters with spaces)
- Significance; Innovation; Specific aims and approach; and Scientific team and environment (4,500 characters with spaces)
- Tables and figures (one page limit, PDF upload)
- References (one page limit)
- Biosketch (five page limit): new style NIH Biosketch format. Include relevant details of applicant’s career trajectory as related to this proposal.
- Also include a Biosketch for all key personnel.
Applicants must submit a pre-application in order to be considered for funding and will be notified in October as to whether or not they are invited to submit full grant proposals. Full applications will not be accepted unless notification of invitation has been received from PKDF.
- Grant resubmission response to reviewer comments (6000 characters with spaces): must describe nature and impact of the revision and summarize the changes made to the application since the last submission.
- Proposal Summary/Abstract (4000 characters with spaces) and its relevance to PKD research. Describe project in a scientific abstract that is understandable to a multidisciplinary group of scientific reviewers.
- Impact statement (4000 characters with spaces) written for the lay audience that addresses relevance to the stakeholder/ patient community. See our Guidance for Reviewers with more details on how the Stakeholder Reviewers will be asked to score your application.
- Resources and environment (4000 characters with spaces): Include brief description of laboratory space, equipment, clinical facilities (if relevant), access to patient populations (if relevant) and other resources necessary for the project.
- Research Plan:
- Section 1 (one single page):
- Specific aims and rationale
- Section 2 (up to 8 pages):
- Significance
- Innovation
- Approach (including Rationale, Background and Preliminary studies, Research design, Expected outcomes, Concerns and Alternative strategies)
- Statistical analyses
- Rigor, Reproducibility and Transparency (including Scientific premise/Quality of prior research, and Scientific rigor/Strategies for unbiased experimental design)
- Section 1 (one single page):
- Young Investigator Award Justification (if applicable, one-page limit): outline the applicant’s interest, eligibility, and scope of research for the potential third year of funding.
- References (no page limit): citations of relevant publications
- Budget and Justification in United States dollars (see Funding section for details)
- Biosketch (five-page limit): new style NIH Biosketch format. Must include a Biosketch for any key personnel and co-investigators.
- Letters of Support from Collaborators, Contributors, and Consultants (not required; quantity not limited). Those qualifying for the Young Investigators Award may also want to provide a professional reference letter speaking toward the researcher’s individual quality as a scientist (maximum of 2 reference letters).
- Other support (no page limit): new style NIH format including current funding, pending funding for all key personnel. More information here.
- Signed IRB approval and summary of clinical protocol (or letter confirming that IRB approval will be obtained before start of project/funds are awarded), if applicable
- Signed IACUC approval of animal use protocol (or letter confirming that IACUC approval will be obtained before start of project/funds are awarded), if applicable
-
Eligibility Criteria
Applicants must have an M.D., Ph.D., or equivalent degree and hold a faculty appointment or equivalent at the institution where research will be conducted at the time of award.
Researchers are invited to apply from all over the world and do not need to be United States citizens.
No fellowships will be awarded under this RFA, although salary support for personnel working on the project may be requested.
Applicants may only submit one grant proposal per funding cycle.
-
Application Review Procedures
The PKD Foundation strives to be transparent in our decision-making processes. We rely on our grant review committees who develop recommendations for funding as well as the process we use as a Foundation to make funding decisions. Learn more here.
-
Funding
Award amounts will equal $120,000 direct costs per year for two years, for a total grant award of $240,000 (or $360,000 for a three-year Young Investigator Award see: Young Investigator Award.)
Future-year funding is dependent upon the availability and interim research progress. Awarded funds must be used solely for the purposes specified in the proposal submitted to and approved by the PKD Foundation as executed by the investigator and institution in strict compliance with the budget attached to the application.
Please note the following restrictions on salary, travel and indirect costs:
- No indirect costs are paid on this award.
- No more than 50% of the direct costs ($60,000) may be used for the applicant’s or other personnel’s salary. Any use of the award for salary support must be justified in the application.*
- Consultant costs cannot exceed $10,000; equipment costs cannot exceed $12,000.
- No more than $1,500 per year may be used for travel. More funds can be requested if intended to apply to PKDConnect Conference attendance.
- Successful applicants may not hold any other research funding from the PKD Foundation at the time funding of this grant begins.
- Applicants with existing funding from other sources will be eligible to apply for this award if there is no scientific overlap between the new application and existing or anticipated funding.
- All current or potential funding must be disclosed at the time of application.
*Salary and equipment cost limitations may be waived on research involving epidemiology/data analysis research or other proposals requiring heavy personnel support. Please contact research@pkdcure.org with details of your project to be considered.
-
Young Investigator Award (YIA)
An optional third year of support will be available to a young investigator(s) to support the transition of a junior scientist to an independent investigator.
Specific eligibility criteria not necessary at the time of application, but required by start of funding include:
- Primary faculty appointments are not required at time of application but must be held by start of funding
- A letter of support is required from the department/division chair outlining the applicants’ path to independence and institutional/divisional commitment to the candidate’s research career development (commitment to the candidate having ability to devote required effort to activities under the award, access to appropriate office/laboratory space etc.,). If the applicant is a post-doctoral fellow at time of award submission, the letter needs to provide assurance of promotion to a faculty appointment at time of award initiation.
- No other career development award may be held (e.g., NIH K-award or equivalent)
- No major research award may be held (in the role of lead investigator) (e.g., NIH R01 or equivalent)
- No more than 7* years from completing post-doctoral or clinical fellowship training
*does not include parental leave or FMLA
Interested applicants will need to clearly outline their interest, eligibility, and scope of research for this third year of funding. Grant applications should be written for the standard two-year proposal; a section will be provided for those applying to the YIA to provide an additional page justification.
-
Application Resubmissions
Applicants are restricted to one application resubmission and will be asked to provide a one-page response to reviewer comments. Thereafter, the application must be submitted as a new application.
-
Reporting Requirements
Grantees must submit an annual Progress Report to be submitted along with a Financial Report. As part of these reports, a brief (one or two paragraph) summary written for the lay public must be included. Although Research Grant and Fellowship Awards are for a two-year period, the PKD Foundation reserves the right to terminate any grant if there has been inadequate research progress during the first year of the award.
-
Attribution
A stipulation to all awards is appropriate attribution of the PKD Foundation in any publication, news release, presentation, etc. that results from work funded by the award. The PKD Foundation must also receive a copy of the publication and/or news release. This responsibility extends beyond the interval of provided funding.
Grantees are asked to please use language similar to the following: This research was funded by a grant from the Polycystic Kidney Disease Foundation, pkdcure.org. The Foundation had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
-
Intellectual Property Policy
All research projects funded by the PKD Foundation are subject to its intellectual property policy. By accepting a PKD Foundation award for a research project, the Principal Investigator or other personnel contributing to and working on the project, as well as the Institution(s) with which they are affiliated, agree to be bound by the terms and conditions of this policy.
All research projects funded by the PKD Foundation are subject to its intellectual property policy. Details can be found <a href=”https://pkdcure.org/wp-content/uploads/2025/06/PKD-Foundation-Patent-and-IP-Policy-July-2024.pdf” target=”_blank” rel=”noopener”>here</a>.
-
Liability Policy & Reporting Responsibilities
The PKD Foundation serves as a grantor not a sponsor for research grant projects. For those involving human subjects, the responsibility for liability issues and all reporting requirements including local, state, and federal regulations and requirements including those of the FDA, will reside with the sponsoring institution, not the PKD Foundation.
-
Conflict of Interest
Any relationship between the investigators and any industrial collaborator must be disclosed in the application.
-
Grants Policy Statement Regarding Sexual Harassment in the Workplace
Prior to releasing funding, the PKD Foundation will require an Authorized Organizational Representative to certify by means of a signed letter on institutional letterhead, institutional commitment to ensuring:
- Proper policies, procedures and oversight are in place to prevent discriminatory harassment and other discriminatory practices, and;
- Commitment to respond promptly and appropriately to allegations of discriminatory practices.
Failure to provide the signed letter will result in withdrawal of the application/funding. The full Foundation policy can be found here.
-
Formatting Requirements
Font size and types, margins, and line spacing requirements are necessary to ensure readability. Applications that do not strictly adhere to the following guidelines will be administratively withdrawn.
- Font size: Text must be 11 points or larger. Smaller text in figures, graphs, diagrams, and charts is acceptable, as long as it is clearly legible when the page is viewed at 100%.
- Some PDF conversion software reduces the font size. It is important to confirm that the final PDF document complies with the font requirements.
- Text fonts: Please use one of the following:
- Arial
- Georgia
- Helvetica
- Page margins: Please use 1-inch margins from top, bottom, left and right aspects of each page. The NIH Biosketch may use 1/2 inch margins.
- Line spacing: No more than six lines per vertical inch (e.g., text using Arial font size 11 would need to be at least single (1.0) spaced).
- Text color: Though not required, black or other high-contrast text colors are recommended since they print well and are legible to the largest audience.
*All images, graphs, charts, etc. should be included in the project plan section of the application.
For general guidance how to structure and write a grant application consider NIH resources (e.g., “Format and Write Applications” or “Research Forms“)
If you have any questions, please contact research@pkdcure.org.
- Font size: Text must be 11 points or larger. Smaller text in figures, graphs, diagrams, and charts is acceptable, as long as it is clearly legible when the page is viewed at 100%.